ORIGINAL RESEARCH article
Front. Pediatr.
Sec. Pediatric Infectious Diseases
Volume 13 - 2025 | doi: 10.3389/fped.2025.1627428
Clinical Characteristics and Factors Associated with Severe COVID-19 among Hospitalized Pediatric Patients: A Retrospective Cohort Study in the Chaoshan Region of China
Provisionally accepted
Xianyao Wang*
Ruiling MaWenshan ZhongHaipeng LinHachao ZhouZhiwei XiaoShaofen LinYutao GuoXufeng ZhengMingxiang Lin- Shantou Central Hospital, Shantou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Since 2019, COVID-19 has substantially impacted global public health. Although pediatric cases generally manifest with mild symptoms, severe and even fatal outcomes have occurred. Despite the decreased viral transmissibility and pathogenicity observed in the post-pandemic era, identifying early clinical indicators for severe pediatric COVID-19 remains crucial.A retrospective cohort study analyzed 287 hospitalized pediatric COVID-19 patients admitted from December 2022 to August 2023. Clinical and laboratory data were compared between severe/critical and mild/moderate groups using univariable and multivariable analyses.Among hospitalized patients, 82.2% were under 3 years, and severe or critical illness occurred in 32.8%. Fatigue (OR = 2.505, 95% CI: 1.359-4.615, P = 0.003) and hoarseness (OR = 2.781, 95% CI: 1.188-6.510, P = 0.018) were independent predictors of severity in multivariable analysis. In univariable analysis, elevated white blood cell counts, neutrophil percentage, procalcitonin (PCT), and reduced bicarbonate (CO₂) levels were also significantly associated with severe disease. All deaths (n=3) involved children aged 1-1.5 years with acute necrotizing encephalopathy (ANE), two of whom also met diagnostic criteria for multisystem inflammatory syndrome in children (MIS-C).Pediatric COVID-19 hospitalizations predominantly involved children under 3 years of age. Fatigue was independently associated with severe or critical illness, potentially indicating early neurological involvement. Hoarseness was frequently observed in severe cases. Based on our cohort, particular attention may be warranted for children aged 1-1.5 years presenting with neurological symptoms, as all fatal cases (n = 3) in this age group were associated with acute necrotizing encephalopathy (ANE), and two were additionally complicated by multisystem inflammatory syndrome in children (MIS-C).
Keywords: SARS-CoV-2, COVID-19, hospitalized children, Severe disease, Neurological involvement, acute necrotizing encephalitis (ANE)
Received: 12 May 2025; Accepted: 05 Aug 2025.
Copyright: © 2025 Wang, Ma, Zhong, Lin, Zhou, Xiao, Lin, Guo, Zheng and Lin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xianyao Wang, Shantou Central Hospital, Shantou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.